Last reviewed · How we verify
GSK Biologicals' HPV vaccine 580299
GSK Biologicals' HPV vaccine 580299 is a Biologic drug developed by GlaxoSmithKline. It is currently FDA-approved. Also known as: Cervarix.
At a glance
| Generic name | GSK Biologicals' HPV vaccine 580299 |
|---|---|
| Also known as | Cervarix |
| Sponsor | GlaxoSmithKline |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects (PHASE3)
- Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females (PHASE4)
- Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls (PHASE3)
- Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299) (PHASE3)
- Safety and Immunogenicity of GlaxoSmithKline Biologicals' HPV Vaccine 580299 (Cervarix) in HIV Infected Females (PHASE2)
- Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age (PHASE3)
- Efficacy, Immunogenicity and Safety of GSK Biologicals' HPV GSK 580299 Vaccine in Healthy Chinese Female Subjects (PHASE3)
- Immunogenicity and Safety of GSK Biologicals' HPV Vaccine 580299 in Healthy Japanese Females 10-15 Years of Age (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- GSK Biologicals' HPV vaccine 580299 CI brief — competitive landscape report
- GSK Biologicals' HPV vaccine 580299 updates RSS · CI watch RSS
- GlaxoSmithKline portfolio CI
Frequently asked questions about GSK Biologicals' HPV vaccine 580299
What is GSK Biologicals' HPV vaccine 580299?
GSK Biologicals' HPV vaccine 580299 is a Biologic drug developed by GlaxoSmithKline.
Who makes GSK Biologicals' HPV vaccine 580299?
GSK Biologicals' HPV vaccine 580299 is developed and marketed by GlaxoSmithKline (see full GlaxoSmithKline pipeline at /company/gsk).
Is GSK Biologicals' HPV vaccine 580299 also known as anything else?
GSK Biologicals' HPV vaccine 580299 is also known as Cervarix.
What development phase is GSK Biologicals' HPV vaccine 580299 in?
GSK Biologicals' HPV vaccine 580299 is FDA-approved (marketed).
Related
- Manufacturer: GlaxoSmithKline — full pipeline
- Also known as: Cervarix
- Compare: GSK Biologicals' HPV vaccine 580299 vs similar drugs
- Pricing: GSK Biologicals' HPV vaccine 580299 cost, discount & access